💊FDA Approval | #Omisirge
First cellular therapy for severe aplastic anemia (#SAA) — Omisirge (omidubicel-onlv), the first #HSCT option for patients without a compatible donor. Restores blood & immune system.Faster recovery.Orphan Drug & Priority Review
🔗https://ow.ly/1PhU50XG3OJ